Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluation of potential of targeted sequencing through mutational signature simulation

PLOS One(2025)10.1371/journal.pone.0326071Source: DataRank Database

Evaluation of potential of targeted sequencing through mutational signature simulation is a research paper published in PLOS One (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldIDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Yiwei Ling ORCID,Hiroshi Ichikawa ORCID,Toshifumi Wakai ORCID,Shujiro Okuda ORCID,Kazuya Kodama

Live enrichment

PubMed:23304386

Japan Society for the Promotion of Science

Grant: 22K19556

Japan Society for the Promotion of Science

Grant: 25K02714

goldLicense: cc-by

publisherhttps://doi.org/10.1371/journal.pone.0326071

publisherhttps://dx.plos.org/10.1371/journal.pone.0326071

repositoryhttps://doaj.org/article/e1301622dc474f069d2be38f3924ab85

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12193913